PCOS and Risk for Autoimmune Disease: An Overlooked Driver of Infertility and Miscarriage

Polycystic ovary syndrome is often approached through a hormonal and metabolic lens. Conversations typically focus on ovulation, hormone levels, and insulin resistance. While these are important, they do not fully explain why many individuals with PCOS continue to struggle with infertility or experience recurrent pregnancy loss despite treatment.

A growing body of research highlights a deeper and often overlooked contributor: immune dysfunction. PCOS is increasingly understood not only as an endocrine and metabolic condition, but also as a state of chronic low grade inflammation with meaningful effects on the immune system. Understanding this connection can fundamentally change how we assess and support fertility in individuals with PCOS.

PCOS as an Immune and Inflammatory Condition

In addition to hormonal imbalance and insulin resistance, PCOS is associated with persistent activation of the immune system. This can include elevated inflammatory cytokines and shifts in immune cell activity that create a pro-inflammatory internal environment.

This inflammatory state does not remain isolated. It can affect ovarian function, egg quality, and the uterine environment, all of which are essential for successful conception and implantation. Over time, this ongoing immune activation can also contribute to a broader pattern of immune dysregulation. This is where the connection between PCOS and risk for autoimmunity becomes especially important.

The Increased Risk of Autoimmune Disease in PCOS

Individuals with PCOS have a significantly higher risk of developing autoimmune conditions compared to the general population. Large cohort data suggests upwards of 50 percent increased overall risk of autoimmune disease. The strongest associations have been observed with conditions such as autoimmune thyroid disease, particularly Hashimoto’s thyroiditis, as well as type 1 diabetes and other immune mediated conditions.

Even in cases where a formal autoimmune diagnosis is not present, there is often evidence of immune activation in the form of elevated autoantibodies. These may include antinuclear antibodies, antithyroid antibodies, and antiphospholipid antibodies, all of which have been linked to impaired reproductive outcomes. This means that for many individuals with PCOS, the immune system may be contributing to fertility challenges in ways that are not immediately obvious through standard testing and even in the absence of any obvious symptoms.

How Immune Dysfunction Affects Fertility

Successful conception and pregnancy require a highly coordinated immune response. The body must allow an embryo, which is genetically distinct, to implant and develop without triggering rejection. This requires a careful balance between pro-inflammatory and regulatory immune immune signals. In PCOS, this balance is often disrupted. The immune system tends to shift toward a more inflammatory state, with increased activity of immune pathways that can interfere with implantation. At the same time, regulatory mechanisms that normally promote tolerance, particularly during early pregnancy, may be reduced.

Within the ovary, inflammation can impair follicular development and reduce egg quality through oxidative stress and cellular damage. Within the uterus, immune dysregulation can alter endometrial receptivity, making it more difficult for an embryo to implant successfully.

These changes create a scenario where fertilization may occur, but implantation is less likely to succeed or be sustained.

Autoimmunity, Implantation Failure, and Miscarriage

The presence of autoimmune activity or autoantibodies adds another layer of complexity. These immune factors can influence the uterine environment in several ways, including promoting inflammation, disrupting blood flow to the developing placenta, and interfering with the normal processes required for embryo attachment and growth.

As a result, individuals with PCOS are at a higher risk of miscarriage, with research suggesting upwards of 1.5 times increased risk compared to those without PCOS. Recurrent pregnancy loss is also more commonly observed in this population, and immune dysfunction is increasingly recognized as a contributing factor. This includes not only overt autoimmune disease but also subtler immune imbalances that may not be captured through routine screening.

Why a More Comprehensive Assessment could make a Valuable Difference

When PCOS is viewed only through the lens of hormones and blood sugar, important drivers of infertility and pregnancy loss can be missed. For individuals who are not responding to standard treatment or who have experienced repeated losses, a broader assessment is often warranted.

This may include evaluating markers of inflammation, screening for autoimmune conditions when clinically appropriate, and considering how lifestyle, nutrition, and environmental factors may be influencing immune function. By expanding the assessment beyond conventional parameters, it becomes possible to identify patterns that help explain persistent reproductive challenges and guide more targeted support.

A More Complete Approach to Treatment

Because PCOS is multifactorial, treatment must reflect that complexity. Addressing immune dysfunction does not typically rely on a single intervention, but rather on a coordinated approach that supports the body as a whole. Lifestyle factors play a central role. Nutrition that emphasizes anti-inflammatory diets or focused on improving metabolic health, personalized physical activity plans, sleep and recovery optimization, and stress management can all help reduce systemic inflammation and improve immune balance. These foundational strategies often have meaningful downstream effects on hormonal and metabolic health as well.

Metabolic support remains important, particularly in the context of insulin resistance, as improving metabolic function can indirectly reduce inflammatory signaling. At the same time, targeted strategies to support immune regulation and gut health may be considered, depending on the individual presentation. In some cases, collaboration with other members of the healthcare team may be appropriate when autoimmune conditions or more complex immune patterns are identified.

Conclusion

PCOS is not solely a hormonal condition, nor is it limited to blood sugar dysregulation. It is a complex, interconnected condition involving the endocrine, metabolic, and immune systems.

For individuals experiencing infertility or recurrent pregnancy loss, the immune component deserves careful consideration. Recognizing and addressing this layer can provide important insight into why challenges are occurring and open the door to more personalized and effective care.

---

Disclaimer: This blog is for informational purposes only and should not be taken as medical advice. Always consult with your Naturopathic Doctor before starting any new supplement, especially during fertility treatments like IVF.

About Dr. H. Singh, ND

Dr. H. Singh is a Fertility Naturopath based in Ottawa with over ten years of experience focusing exclusively on reproductive health.

He works with individuals and couples across Ontario and Quebec, supporting patients trying to conceive naturally or alongside treatments such as IUI and IVF.

Care focuses on evidence informed strategies to support egg quality, sperm health, hormonal balance, implantation, and early pregnancy.